These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 7684043)
1. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. Blei F; Wilson EL; Mignatti P; Rifkin DB J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043 [TBL] [Abstract][Full Text] [Related]
2. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells. Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Montesano R; Kumar S; Orci L; Pepper MS Lab Invest; 1996 Aug; 75(2):249-62. PubMed ID: 8765325 [TBL] [Abstract][Full Text] [Related]
5. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Pepper MS; Wasi S; Ferrara N; Orci L; Montesano R Exp Cell Res; 1994 Feb; 210(2):298-305. PubMed ID: 7507853 [TBL] [Abstract][Full Text] [Related]
6. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. Kim MH J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886 [TBL] [Abstract][Full Text] [Related]
7. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system. Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807 [TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. Odekon LE; Sato Y; Rifkin DB J Cell Physiol; 1992 Feb; 150(2):258-63. PubMed ID: 1734031 [TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. Flaumenhaft R; Abe M; Mignatti P; Rifkin DB J Cell Biol; 1992 Aug; 118(4):901-9. PubMed ID: 1380001 [TBL] [Abstract][Full Text] [Related]
10. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells. Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964 [TBL] [Abstract][Full Text] [Related]
11. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells. Peverali FA; Mandriota SJ; Ciana P; Marelli R; Quax P; Rifkin DB; Della Valle G; Mignatti P J Cell Physiol; 1994 Oct; 161(1):1-14. PubMed ID: 7523424 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators. Korner G; Bjornsson TD; Vlodavsky I J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2. Liu JW; Wei DZ; Du CB; Zhong JJ Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716 [TBL] [Abstract][Full Text] [Related]
14. Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. Pepper MS; Vassalli JD; Wilks JW; Schweigerer L; Orci L; Montesano R J Cell Biochem; 1994 Aug; 55(4):419-34. PubMed ID: 7525617 [TBL] [Abstract][Full Text] [Related]
15. A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method. Yasunaga C; Nakashima Y; Sueishi K Lab Invest; 1989 Dec; 61(6):698-704. PubMed ID: 2481153 [TBL] [Abstract][Full Text] [Related]
16. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. Flaumenhaft R; Moscatelli D; Saksela O; Rifkin DB J Cell Physiol; 1989 Jul; 140(1):75-81. PubMed ID: 2738111 [TBL] [Abstract][Full Text] [Related]
17. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618 [TBL] [Abstract][Full Text] [Related]
18. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells. Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589 [TBL] [Abstract][Full Text] [Related]
19. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254 [TBL] [Abstract][Full Text] [Related]
20. Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells. Ku PT; D'Amore PA J Cell Biochem; 1995 Jul; 58(3):328-43. PubMed ID: 7593255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]